Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors Aft... (on as possible unless it is almost time ...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery

Date:8/27/2008

on as possible unless it is almost time for their next dose, in which case the missed dose should not be taken. A double dose should not be taken to make up for any missed dose.

Disclaimer

The foregoing release contains forward-looking statements that can be identified by terminology such as "priority review", "risk", "commitment", "potentially", "will", "if approved", "possibly", "encouraging", "would", or similar expressions, or by express or implied discussions regarding potential new indications or labelling for Gleevec or regarding potential future revenues from Gleevec. Such forward-looking statements reflect the current views of the Company regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results with Gleevec to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that Gleevec will be approved for any additional indications or labelling in any market. Nor can there be any guarantee that Gleevec will achieve any particular levels of revenue in the future. In particular, management's expectations regarding Gleevec could be affected by, among other things, unexpected regulatory actions or delays or government regulation generally; unexpected clinical trial results, including unexpected new clinical data and unexpected additional analysis of existing clinical data; the company's ability to obtain or maintain patent or other proprietary intellectual property protection; competition in general; government, industry and general public pricing pressures, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is p
'/>"/>

SOURCE Novartis
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12
Related biology technology :

1. Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia
2. TorreyPines Therapeutics Receives NASDAQ Deficiency Notice
3. Omaxe Infrastructure & Construction Private Ltd Receives LoI for Construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP With Construction Value of Approx 250 Crores
4. Caliper Life Sciences Receives $1.1 Million Task Order from the EPAs ToxCast(TM) Screening Program
5. Biotest Diagnostics Receives FDA Clearance for Full Line of Traditional Blood Bank Reagents
6. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
7. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
8. CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
9. SGX - Lilly Merger Offer Receives Positive Opinions From Proxy Advisory Firms
10. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
11. Medicsight Receives Brazilian State Food and Drug Administration Approval for ColonCAD Software

Post Your Comments:

(Date:12/15/2009)... 15 The Mosaic Company (NYSE: MOS ... 2010 earnings results and financial tables on Tuesday, January ... New York Stock Exchange. Results will be available ... Company will host a conference call with presentation slides ... The call will begin at 11:00 a.m. Eastern ...

(Date:12/15/2009)... -- The Center for Business Intelligence (CBI), ... to announce the full agenda for the ... Congress . The forum will take place ... 2010. ,, Over 1,500 senior-level Finance, Accounting, ... premier event since its inception, and this ...

(Date:12/15/2009)... Thomson Reuters ... become the first drug pipeline database to fully ... This highly anticipated new content is being provided ... ,, Thomson Pharma will offer ... press releases, conferences, and other sources across all ...

(Date:12/15/2009)... of several innovative new programs to aid cash-strapped entrepreneurs ... climate. The first is aimed at entrepreneurs and ... a period of 6, 12, 18, or 24 months ... The second is aimed at more established businesses and ... 12 month period at discounted rates, and even the ...

Breaking Biology Technology:Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call 2 CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress 2 Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2 The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses 2

[0] Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call [0] CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress [0] Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials [0] The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses

... Comprehensive Investor Relations and Media Outreach to ... Transdel,Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP),( ... focused on developing and commercializing non-invasive, topically,administered ... a thirteen-year-old, highly recognized corporate communications,firm based ...

... Research Organization Exceeds Expectations, MEMPHIS, Tenn., ... Research,Organization exclusively focused on oncology, announced today ... projections as the company continues,to experience banner ... ability to consistently exceed client expectations, and ...

... - ("Stem Cell Sciences", "SCS", "the Company"), ... focused on the,commercialisation of stem cells and stem ... agreement with CHDI Foundation, Inc., to support the,standardisation ... lines. CHDI,is a US non-profit organisation pursuing treatments ...

Other Biology Technology:Transdel Pharmaceuticals, Inc. Retains The Investor Relations Group 2 Transdel Pharmaceuticals, Inc. Retains The Investor Relations Group 3 ACORN CRO Continues Growth in Strong Third Quarter 2 Stem Cell Sciences Enters into Services Agreement with Huntingdon's Disease Research Group, CHDI Foundation Inc. 2 Stem Cell Sciences Enters into Services Agreement with Huntingdon's Disease Research Group, CHDI Foundation Inc. 3 Stem Cell Sciences Enters into Services Agreement with Huntingdon's Disease Research Group, CHDI Foundation Inc. 4

Transdel Pharmaceuticals, Inc. Retains The Investor Relations Group ACORN CRO Continues Growth in Strong Third Quarter Stem Cell Sciences Enters into Services Agreement with Huntingdon's Disease Research Group, CHDI Foundation Inc.

(Date:12/15/2009)... 15, 2009 Economics, environmental impacts, social dynamics, ... influence the overall success of an agroecosystem. Positive ... system, forcing individuals and social groups to continuously ... survive. , Experiential learning theory suggests that ... firsthand experiences. Such lessons are especially valuable for ...

(Date:12/15/2009)... mammoths and ancient American horses may have been ... years longer than previously thought. After plucking ancient ... team of researchers used cutting-edge techniques to uncover ... samples dated to between 7,600 and 10,500 calendar ... one population of these now-extinct mammals endured longer ...

(Date:12/15/2009)... in German . , Leipzig: Species distribution ... future distribution of mammals. This is the finding of ... European mammals. The researchers analysed data on species distribution, ... phylogenetic information of the species. Judging by the large ... mammals seem to adapt fast to changing climatic conditions. ...

Breaking Biology News(10 mins):Experiential learning teaches change and adaptation 2 Late-surviving megafauna exposed by ancient DNA in frozen soil 2 Late-surviving megafauna exposed by ancient DNA in frozen soil 3 Late-surviving megafauna exposed by ancient DNA in frozen soil 4 Species distribution models are of only limited value for predicting future mammal distributions 2 FRC 3A Senate Votes to Proceed with Abortion Funding Debacle 61883 1 FRC 3A Senate Votes to Proceed with Abortion Funding Debacle 61883 2 River Blindness 28Onchocerciasis 29 Reduced By Nearly One Third In At Risk Populations In Six Countries 61879 1 River Blindness 28Onchocerciasis 29 Reduced By Nearly One Third In At Risk Populations In Six Countries 61879 2 River Blindness 28Onchocerciasis 29 Reduced By Nearly One Third In At Risk Populations In Six Countries 61879 3 River Blindness 28Onchocerciasis 29 Reduced By Nearly One Third In At Risk Populations In Six Countries 61879 4 KINAXO Completes Financing Round to Enhance Biomarker Development 10849 1 KINAXO Completes Financing Round to Enhance Biomarker Development 10849 2 KINAXO Completes Financing Round to Enhance Biomarker Development 10849 3

[0] Experiential learning teaches change and adaptation [1] Late-surviving megafauna exposed by ancient DNA in frozen soil [0] Species distribution models are of only limited value for predicting future mammal distributions

... have discovered epigenetic changes (i.e. chemical changes to ... sequence) in individuals with schizophrenia and bipolar disorder. ... research, and this groundbreaking data may be a ... major psychosis. , Dr. Arturas Petronis, senior scientist ...

... as a fuel alternative will worsen pollution in the Gulf ... aquatic life, according to University of British Columbia researcher Simon ... and Chris Kucharik of the University of Wisconsin quantify the ... in a waterway. Their findings will appear in the March ...

... The growth in China,s carbon dioxide (CO2) emissions is ... atmospheric greenhouse gases much more difficult, according to a ... Berkeley, and UC San Diego. , Previous estimates, including ... say the region that includes China will see a ...

Other Biology News:Epigenetic changes discovered in major psychosis 2 US rush to produce corn-based ethanol will worsen 'dead zone' in Gulf of Mexico: UBC study 2 New UC analysis shows alarming increase in expected growth of China's carbon dioxide emissions 2 New UC analysis shows alarming increase in expected growth of China's carbon dioxide emissions 3

Epigenetic changes discovered in major psychosis US rush to produce corn-based ethanol will worsen 'dead zone' in Gulf of Mexico: UBC study New UC analysis shows alarming increase in expected growth of China's carbon dioxide emissions

Fast, sensitive quantitation of Mouse IgM concentration....

Competitors to lower non-specific signal...

ExonBio Service provides one-stop recobinant protein shopping from cloning, expression and purification. Price including gene cloning....

Anti-ZFP200 Family: Zinc Finger Peptide Sequence: CGKSFNHKTNLNKHER...

Biology Products:

Mouse IgM EIA Kit from Assay Designs/Stressgen Bioreagents 5X Competitor II (Mouse) from Takara Mirus Bio Protein Expression Service (Bacterial) from Exon BioSystems Rabbit Anti-ZFP200 Polyclonal Antibody, Unconjugated from CeMines

Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors Aft...(on as possible unless it is almost time ...)